Abstract Body

Background: Highly active antiretroviral therapy (HAART) reduces morbidity and mortality due to human immunodeficiency virus (HIV), however cognitive impairment continues to persist. It remains uncertain whether HAART regimens with a high degree of central nervous system penetration effectiveness (CPE) exert beneficial neurological outcomes in HIV-infected (HIV+) individuals on stable treatment. The present cross sectional study examined the relationship between HAART CPE and brain integrity in HIV+ adults.

Methods: Sixty-four HIV-infected individuals (18-82 years old) on stable HAART (≥ 3 months) were assigned a CPE score using a published ranking system and divided into high (≥ 7; n=35) and low (< 7; n=29) CPE groups. All participants completed laboratory and neuropsychological testing in addition to structural neuroimaging. Neuropsychological tests included measures known to be sensitive to HIV with values converted into standardized scores (NPZ-4) based on published normative scores. A semi-automated methodology was utilized to assess brain volumetrics within cortical (white and grey matter) and subcortical (caudate, putamen, and thalamus) regions of interest often affected by HIV. Primary analyses utilizing linear regression were computed to examine the relationship between total CPE score with NPZ-4 and brain volumetrics. Differences in demographic (age, education, race, gender) and viral factors (recent viral load, duration of infection, recent CD4, CD4 nadir) between high (≥ 7) and low (< 7) CPE groups were examined utilizing independent sample t tests and chi-squared analyses. Secondary analyses utilized analysis of variance to assess NPZ-4 and brain volumetric differences between HIV+ individuals with high and low CPE scores.

Results: Primary analyses revealed no significant relationships between neuropsychological performance (F(1,63)=1.01; p > .05) or brain volumetrics (F(5,67)= .27, p > .05) and total CPE score utilizing linear regression. There were no differences in demographic or viral factors between the two CPE groups. Furthermore, no significant relationships were observed in the secondary analyses when individuals were categorically divided into high or low CPE groups (p > .05).

Conclusions: Long-term HAART regimens with a high degree of CPE were not associated with significantly improved neuropsychological or neuroimaging outcomes in HIV+ adults. Results suggest that alternate mechanisms may potentially contribute to better neurological outcomes in the era of HAART.